STAT3 and plasma cell myeloma: Our study demonstrate that up-regulated leptin could stimulate proliferation and reduce the anti-tumor effect of chemotherapy in multiple myeloma possibly via activating AKT and STAT3 pathways, and leptin might be one of the potential therapeutic targets for treating myeloma.